Immusorba TR and immusorba PH: Basics of design and features of functions

Therapeutic Apheresis

Volumn 4, Issue 2, 2000, Pages 127-134

  Yoshida, Makoto ^a   Tamura, Yuichi ^a   Yamada, Yukihiro ^a   Yamawaki, Naokuni ^a   Yamashita, Yasuhiko ^a  

^a Asahi Kasei Medical Co   (Japan)

Author keywords

Autoantibody; Immunoadsorbent; Phenylalanine; Polyvinyl alcohol; Tryptophan

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; GLOBULIN; PHENYLALANINE; POLYVINYL ALCOHOL; RHEUMATOID FACTOR; TRYPTOPHAN;

ADSORPTION; ARTICLE; CHEMICAL STRUCTURE; GUILLAIN BARRE SYNDROME; IMMUNOADSORBENT; MYASTHENIA GRAVIS; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

EQUIPMENT DESIGN; FEMALE; GUILLAIN-BARRE SYNDROME; HISTORY, 20TH CENTURY; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOSORBENTS; MALE; MYASTHENIA GRAVIS;

EID: 0034049540     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2000.004002127.x     Document Type: Article

References (22)

1. Yamazaki Z, Fujimori Y, Takahama T, Wada T, Kasama M, Morioka M, Abe T, Yamawaki N, Inagaki K. Efficiency and biocompatibility of new immunoadsorbent. Trans Am Soc Artif Intern Organs 1982;28:318-23.
2. Yamawaki N. Artificial receptors of rheumatoid factor and application to plasma purification. J Synthet Organ Chem Jpn 1985;43:1024-34.
3. Sato T, Anno M, Arai K, Yamawaki N, Kuroda T, Inagaki K. In vitro removal of anti-acetylcholine receptor antibodies with a new immunoadsorbent in sera from myasthenia gravis patients. Prog Artif Organs. ISAO Press, 1983:719-22.
4. 1b antibody from Fisher's syndrome: A new approach to treatment. Neurology 1996;46:1644-51.
5. Takashima H, Ooishi K, Fujishita S, Kanazawa H, Shibuya N. Immunoadsorbent IM-TR interacts at the hinge region of IgG. Ther Plasmapheresis 1989;8:195-7.
6. Okudaira K, Kobayashi N, Yoshizawa H. Effect of immunoadsorbent treatment on auto-antibody levels. Ther Plasmapheresis 1984;4:149-52.
7. Behm E, Falkenhagen D, Zinner G, Courtney JM, Klinkmann H. Interactions of IM-P and IM-T adsorbents with complement components. Ther Plasmapheresis 1986;6:493-8.
8. Fujita S, Yamaji K, Kanai Y, Kawanishi T, Toumyo M, Yokoyama M, Tsuda H, Hashimoto M, Hirose SI. Changes in blood and plasma viscosities after plasmapheresis therapy. Ther Plasmapheresis 1993;12:711-8.
9. Shinoda T, Koh C-S, Arakura H, Yamaguchi E, Katakura M, Yanagisawa N. Immunoadsorption plasmapheresis and plasma exchange in Guillain-Barré syndrome. Ther Plasmapheresis 1993;12:531-4.
10. Jiménez C, Rosenow F, Grieb P, Haupt WF, Borberg H. Adsorption therapy with tryptophan-conjugated polyvinyl alcohol gels in 10 patients with acute Guillain-Barré syndrome. Transfus Sci 1993;14:9-11.
11. 1b antibody in immunoadsorption therapy for Fisher syndrome - Comparison of the removal ability between tryptophan column and phenylalanine column. Clin Neurol 1996;36:323-9.
12. Haupt WF, Borberg H, Rosenow F. Pilot study of a new treatment concept for acute Guillain-Barré syndrome. Transfus Sci 1995;16:139-44.
13. Shibuya N, Nagasato K, Kinoshita N, Kanazawa H, Kihara M. Immunoadsorbent perfusion therapy in patient with myasthenia gravis. In: Shiokawa Y, Inoue N, eds. Current practice in therapeutic plasmapheresis. Amsterdam: Excepta Medica, ICS NO. 694, 1985:166-72.
14. Shibuya N, Kanazawa H, Osame M, Ijichi S, Sato T, Ishigaki Y, Takegami T, Matsumoto A, Doi S, Joichi T. Immunoadsorption therapy for MG: Multi-center trial in single-blind design. Ther Plasmapheresis 1989;8:231-4.
15. Shibamoto T, Akiba T, Maeda M, Sakamoto H, Oshima H, Marumo F, Ujiie K, Suenaga M. Study of immunoadsorbent therapy in five severe cases of myasthenia gravis. Ther Plasmapheresis 1991;9:209-13.
16. Grob D, Simpson D, Mitsumoto H, Hoch B, Mokhtarian F, Bender A, Greenberg M, Koo A, Nakayama S. Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 1995;45:338-44.
17. Koh C-S, Shimada K, Inoue A, Shimazu Y, Yanagisawa N, Shinoda T, Akakura H, Oguchi H. Immunoadsorption plasmapheresis in polymyositis/dermatomyositis: Beneficial effects in four cases. Jpn J Apheresis 1994;13:131-2.
18. Shibuya N, Shirabe S, Nagasato K, Kanazawa H, Kihara M. Immunoadsorbent plasma perfusion therapy in patients with neuroimmunological disorders. Ther Plasmapheresis 1984;4: 165-9.
19. Yamazaki Z, Fujimori Y, Iizuka I, Kanai F, Idezuki Y, Takahama T, Asano K, Takahashi T, Ogita T, Miyamoto Y, Yamawaki N, Yoshizawa H, Inagaki K, Tsuda N. Effect of immunoadsorption on patient with rheumatoid arthritis or SLE. Trans Am Soc Artif Intern Organs 1984;30:211-6.
20. Kanazawa H, Nagasato K, Shirabe S, Kihara M, Shibuya N. Change of lymphocyte subsets during plasmapheresis. Ther Plasmapheresis 1984;4:561-5.
21. Amasaki Y, Sagawa A, Baba Y, Katsumata K, Yoshikawa M, Watanabe I, Mukai M, Yasuda I, Nakagawa S. Effect of immunoadsorption therapy on lupus nephritis using immunoadsorbent PH350 column. Ther Plasmapheresis 1989;8:88-92.
22. Yamawaki T, Itoh Y, Shiroshita A, Nakamura Y, Suzuki N. Effect of newly developed immunoadsorbent column (TR-350S) on neurological disorders. Clin Pharm Ther 1997;7: 1233-6.